Edwards Lifesciences Corporation (NYSE: EW) is one of 82 public companies in the “Advanced Medical Equipment & Technology” industry, but how does it weigh in compared to its peers? We will compare Edwards Lifesciences Corporation to similar businesses based on the strength of its dividends, institutional ownership, risk, profitability, valuation, earnings and analyst recommendations.
Insider & Institutional Ownership
82.1% of Edwards Lifesciences Corporation shares are held by institutional investors. Comparatively, 53.1% of shares of all “Advanced Medical Equipment & Technology” companies are held by institutional investors. 2.1% of Edwards Lifesciences Corporation shares are held by company insiders. Comparatively, 16.8% of shares of all “Advanced Medical Equipment & Technology” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
This is a breakdown of recent recommendations for Edwards Lifesciences Corporation and its peers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Edwards Lifesciences Corporation||0||5||14||1||2.80|
|Edwards Lifesciences Corporation Competitors||416||2182||3391||123||2.53|
Edwards Lifesciences Corporation currently has a consensus target price of $120.05, indicating a potential upside of 6.53%. As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 22.27%. Given Edwards Lifesciences Corporation’s stronger consensus rating and higher probable upside, research analysts clearly believe Edwards Lifesciences Corporation is more favorable than its peers.
This table compares Edwards Lifesciences Corporation and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Edwards Lifesciences Corporation||22.16%||27.17%||15.91%|
|Edwards Lifesciences Corporation Competitors||-330.26%||-33.54%||-12.51%|
Volatility & Risk
Edwards Lifesciences Corporation has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500. Comparatively, Edwards Lifesciences Corporation’s peers have a beta of 0.89, meaning that their average share price is 11% less volatile than the S&P 500.
Earnings and Valuation
This table compares Edwards Lifesciences Corporation and its peers gross revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Edwards Lifesciences Corporation||$3.23 billion||$1.05 billion||34.15|
|Edwards Lifesciences Corporation Competitors||$2.02 billion||$430.37 million||-65.52|
Edwards Lifesciences Corporation has higher revenue and earnings than its peers. Edwards Lifesciences Corporation is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Edwards Lifesciences Corporation beats its peers on 11 of the 13 factors compared.
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient’s diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient’s cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.
Receive News & Ratings for Edwards Lifesciences Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edwards Lifesciences Corporation and related companies with MarketBeat.com's FREE daily email newsletter.